A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

NCT00961480 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: sitagliptin phosphate (+) metformin hydrochloride
DRUG: Comparator: metformin 500mg
DRUG: Comparator: sitagliptin
DRUG: Comparator: FMI sitagliptin / metformin 50 mg/500 mg FDC tablet
DRUG: Comparator: FMI sitagliptin/metformin 50 mg/1000 mg FDC tablet
DRUG: Comparator: FMI sitagliptin/metformin 50 mg/850 mg FDC tablet
DRUG: Comparator: metformin 1000 mg
DRUG: Comparator: metformin 850 mg

Sponsor

Merck Sharp & Dohme LLC